RALEXAR Trademark

Trademark Overview

On Thursday, December 17, 2015, a trademark application was filed for RALEXAR with the United States Patent and Trademark Office. The USPTO has given the RALEXAR trademark a serial number of 86853052. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by Alexar Therapeutics, Inc.. The RALEXAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the fields of dermatology, ophthalmology, oncology and neurology, pharmaceuticals and clinical trials
ralexar

General Information

Serial Number86853052
Word MarkRALEXAR
Filing DateThursday, December 17, 2015
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5874546
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the fields of dermatology, ophthalmology, oncology and neurology, pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 28, 2015
Primary Code042
First Use Anywhere DateThursday, March 31, 2016
First Use In Commerce DateThursday, March 31, 2016

Trademark Owner History

Party NameRALEXAR THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameRALEXAR THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameAlexar Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NameAlexar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Monday, December 21, 2015NEW APPLICATION ENTERED
Monday, December 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 4, 2016ASSIGNED TO EXAMINER
Thursday, April 7, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, April 7, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, April 7, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 7, 2016EXAMINER'S AMENDMENT ENTERED
Monday, May 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2017SOU EXTENSION 2 FILED
Tuesday, July 25, 2017SOU EXTENSION 2 GRANTED
Thursday, July 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 29, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 2, 2017SOU TEAS EXTENSION RECEIVED
Thursday, February 2, 2017SOU EXTENSION 1 FILED
Thursday, February 2, 2017SOU EXTENSION 1 GRANTED
Saturday, February 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 25, 2017SOU TEAS EXTENSION RECEIVED
Saturday, February 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 27, 2018SOU TEAS EXTENSION RECEIVED
Friday, July 27, 2018SOU EXTENSION 4 FILED
Tuesday, January 22, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, January 22, 2019SOU EXTENSION 5 FILED
Thursday, February 1, 2018SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2018SOU EXTENSION 3 FILED
Thursday, February 1, 2018SOU EXTENSION 3 GRANTED
Friday, July 27, 2018SOU EXTENSION 4 GRANTED
Tuesday, July 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2019SOU EXTENSION 5 GRANTED
Monday, August 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, August 1, 2019USE AMENDMENT FILED
Monday, August 5, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 8, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

ralexar neurology oncology pharmaceuticals clinical trials ophthalmology dermatology scientific medical research